Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Prevalence of human papillomavirus infection of 65,613 women in East China.

Ge Y, Zhong S, Ren M, Ge Y, Mao Y, Cao P.

BMC Public Health. 2019 Feb 11;19(1):178. doi: 10.1186/s12889-019-6487-9.

2.

Women's knowledge, attitudes and practices (KAP) relating to breast and cervical cancers in rural Zimbabwe: a cross sectional study in Mudzi District, Mashonaland East Province.

Makurirofa L, Mangwiro P, James V, Milanzi A, Mavu J, Nyamuranga M, Kamtauni S.

BMC Public Health. 2019 Jan 24;19(1):109. doi: 10.1186/s12889-018-6333-5.

3.

[Analysis on long-term trends of cervical cancer mortality and years of life lost in Tianjin, 1999-2015].

Zheng WL, Zhang H, Wang DZ, Zhang S, Pang S, Li CK, Jiang GH.

Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Jan 10;40(1):64-69. doi: 10.3760/cma.j.issn.0254-6450.2019.01.013. Chinese.

PMID:
30669733
4.

The Risk of Malignancy in Korean Patients with Rheumatoid Arthritis.

Lee H.

Yonsei Med J. 2019 Feb;60(2):223-229. doi: 10.3349/ymj.2019.60.2.223.

5.

Prevalence and genotype distribution of human papillomavirus among 9945 women from the Nanhai area of Foshan.

Yuan XW, Li YJ, Qiu Q, Luo ZY, Zhao XF.

BMC Infect Dis. 2019 Jan 18;19(1):71. doi: 10.1186/s12879-019-3687-y.

6.

Evaluation of the self-sampling for cervical cancer screening in Bolivia.

Allende G, Surriabre P, Cáceres L, Bellot D, Ovando N, Torrico A, Calle P, Ascarrunz C, Alexander S, Bossens M, Fontaine V, Rodríguez P.

BMC Public Health. 2019 Jan 17;19(1):80. doi: 10.1186/s12889-019-6401-5.

7.

Three-Tiered versus Two-Tiered Classification of Squamous Dysplasia in Cervical Cytology: Results of a Follow-Up Study.

Marquardt K, Ziemke P, Neumann K.

Acta Cytol. 2019;63(1):44-49. doi: 10.1159/000494984. Epub 2018 Dec 5.

PMID:
30517915
8.

Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.

Arbyn M, Xu L.

Expert Rev Vaccines. 2018 Dec;17(12):1085-1091. doi: 10.1080/14760584.2018.1548282. Epub 2018 Nov 29. Review.

PMID:
30495978
9.

Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia

Hosseini MS, Khosravi D, Farzaneh F, Ebrahimi A, Arab M, Ashraf Ganjoie T, Jamdar F, Moridi A, Chehrazi M.

Asian Pac J Cancer Prev. 2018 Nov 29;19(11):3071-3075.

10.

The ecologization of the Papanicolaou stain in the diagnosis of cervical cancer

Rojas-Zumaran V, Moya-Salazar J.

Rev Med Inst Mex Seguro Soc. 2018 Oct 25;56(3):217-225.

PMID:
30365481
11.

Costs and cost-effectiveness of LEEP versus cryotherapy for treating cervical dysplasia among HIV-positive women in Johannesburg, South Africa.

Lince-Deroche N, van Rensburg C, Roseleur J, Sanusi B, Phiri J, Michelow P, Smith JS, Firnhaber C.

PLoS One. 2018 Oct 11;13(10):e0203921. doi: 10.1371/journal.pone.0203921. eCollection 2018. Erratum in: PLoS One. 2019 Feb 12;14(2):e0212391.

12.

Self-perceived competence in early diagnosis of cervical cancer among recently graduated physicians from Lima, Peru.

Zafra-Tanaka JH, Hurtado-Villanueva ME, Saenz-Naranjo MDP, Taype-Rondan A.

PLoS One. 2018 Sep 12;13(9):e0203778. doi: 10.1371/journal.pone.0203778. eCollection 2018.

13.

Exploring Iranian women's perceptions and experiences regarding cervical cancer-preventive behaviors.

Khazaee-Pool M, Yargholi F, Jafari F, Ponnet K.

BMC Womens Health. 2018 Aug 31;18(1):145. doi: 10.1186/s12905-018-0635-8.

14.

[High mortality for cervical cancer in young women from the Metropolitan Area of Buenos Aires].

Aragona A, Soderini A, Moschen H, Bonavia E, Garrido R, Cuneo N.

Medicina (B Aires). 2018;78(4):234-242. Spanish.

15.

Combined pretreatment with 18F-FDG PET/CT and Comet assay guides the concurrent chemoradiotherapy of locally advanced cervical cancer: study protocol for a randomized controlled trial.

Ji S, Hu Q, Zhu J, Chen J, Chen Q, Liu Z, Shen C, Yang R, Sun H, Wu J, Gu K.

Trials. 2018 Aug 3;19(1):416. doi: 10.1186/s13063-018-2800-7.

16.

Attitudes of undergraduate university women towards HPV vaccination: a cross-sectional study in Ottawa, Canada.

Fernandes R, Potter BK, Little J.

BMC Womens Health. 2018 Aug 2;18(1):134. doi: 10.1186/s12905-018-0622-0.

17.
18.

Knowledge of HPV and acceptability of HPV vaccine among women in western China: a cross-sectional survey.

He J, He L.

BMC Womens Health. 2018 Jul 27;18(1):130. doi: 10.1186/s12905-018-0619-8.

19.

Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.

Lin G, Yang LY, Lin YC, Huang YT, Liu FY, Wang CC, Lu HY, Chiang HJ, Chen YR, Wu RC, Ng KK, Hong JH, Yen TC, Lai CH.

Eur Radiol. 2019 Feb;29(2):556-565. doi: 10.1007/s00330-018-5651-4. Epub 2018 Jul 26.

PMID:
30051142
20.

Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.

Swanson M, Ibrahim S, Blat C, Oketch S, Olwanda E, Maloba M, Huchko MJ.

BMC Womens Health. 2018 Jul 3;18(1):116. doi: 10.1186/s12905-018-0586-0.

Supplemental Content

Loading ...
Support Center